Skip to Content

'
Vivek Subbiah, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Vivek Subbiah, MD is currently an Assistant Professor in the Department of Investigational Cancer Therapeutics (A Phase 1 Program), Division of Cancer Medicine, at The University of MD Anderson Cancer Center. After completing his medical school in India, he completed a combined residency in Internal Medicine and Pediatrics at Case Western Reserve University, MetroHealth, Cleveland Ohio.  Dr. Subbiah has a unique training background as he is one of the few physicians in the nation/world to have training in oncology in both adults and children. He is board certified in both Internal Medicine and Pediatrics and has completed fellowships in both adult and pediatric oncology at the MD Anderson Cancer Center. Dr. Subbiah has been working closely with colleagues in Cancer Medicine and Pediatrics to develop novel treatment methods including molecularly targeted therapies, radiopharmaceutical studies and immunotherapeutic strategies to improve the outcomes of AYA with cancer. In addition, by using cutting-edge molecular profiling and the large portfolio of targeted drugs, he is positioning to lead the way in identifying new treatments for the atypical cancers that these young people develop His research interests include adolescent and young adult oncology, phase 1 trials drug development (molecularly targeted therapy, radiopharmaceutical studies and immunotherapeutic studies), and clinical trials with molecularly targeted agents in targetable rare diseases  (eg,sarcomas,NF2). He also has a passion for N-of-ONE studies in cancer patients that have dramatic responses to therapies by in depth analysis through next generation sequencing, morphoproteomics, and other cutting edge methods for analysis of response/ resistance mechanisms.

Research Interests

1.    Adolescent and Young adult oncology

2.    Clinical Trials with molecularly targeted agents in targetable rare diseases ( eg, Sarcomas, NF2, )  

3.    Unusual Responder interest: Dramatic Responses in Cancer patients. Nof-ONE studies. In depth analysis by deep sequencing, morphoproteomics, next generation sequencing and other cutting edge methods for analysis of response/ resistance mechanisms.

4.    Phase 1 trials Drug development ( Targeted therapy, Radiopharmaceutical therapy and Immunotherapy)

Education & Training

Degree-Granting Education

2002 Sri Ramachandra Medical College & Research Institute, Chennai, Chennai, India, MBBS, Bachelor of Medicine and Bachelor of Surgery

Postgraduate Training

7/2011-6/2012 Clinical Fellowship, Adult Medical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Robert Wolff, MD
10/2009-6/2011 Research Fellowship, Investigational Cancer Therapeutics, The Inversity of Texas MD Anderson Cancer Center, Houston, TX, Dr. Razelle Kurzrock, MD
7/2008-6/2011 Clinical Fellowship, Pediatric Hematology/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Susan S. Kelly
7/2005-6/2008 Clinical Residency, Internal Medicine and Pediatrics Combined Residency, Case Western Reserve University School of Medicine, Cleveland, OH, Dr. David Mansour
7/2004-6/2005 Clinical Internship, Internal Medicine and Pediatrics Combined Internship, Case Western Reserve University School of Medicine, Cleveland, OH, Dr. David Mansour, MD
2003 Visiting Scholar, Emergency Medicine, Stanford University Medical Center, Division of Emergency Medicine, Palo Alto, CA, Dr. Swaminatha Mahadevan, MD
2001-2002 Clinical Internship, Medicine and Surgery, Sri Ramachandra Medical College & Research Institute, Chennai, India, Dr. K.V. Somasundaram

Board Certifications

2011 Diplomate of American Board Of Pediatrics (ABP)
2008 Diplomate of American Board of Internal Medicine (ABIM).
2004 Education Commission for Foreign Medical Graduates (ECFMG)

Honors and Awards

2012 The Connie and Jim Walter Fellowship in Sarcoma Research Trainee of the Quarter Award, The University of Texas MD Anderson Cancer Center
2010 Best Survivorship Poster Award, University of Texas MD Anderson Cancer Center
2010 Bayer Healthcare Pharmaceuticals, Inc., Population/Patient Oriented Research
2010 The 2010 Daniel Benedict Gazen Fellowhsip Award, The University of Texas MD Anderson Cancer Center
2009-2010 Trainee of the Quarter Award, The University of Texas MD Anderson Cancer Center
2008 Research Excellence Award, Case Western Reserve University
2008 Trainee Travel Award, Thrombosis Society
2006 Best Case Presentation, Med West Med-Peds Meeting
2004 Pfizer Research Excellence Award, Great Lakes Research Symposium
2000 Oral Presentation in World Health Organization

Last updated: 7/17/2013